Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glycemic Response clinical trials
1 of 5 indexed Glycemic Response trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Glycemic Response: 5 US clinical trials tracked, 1 recruiting.
Glycemic Response is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Scripps Translational Science Institute, running 1 of these trials.
Enrollment posture brief
Registry condition glycemic-response
OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Glycemic Response lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glycemic Response on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glycemic Response is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Glycemic Response research.
Scripps Translational Science Institute accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Glycemic Response trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Glycemic Response research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)
Phynova Group
NCT07333885
PRediction Of Glycemic RESponse Study
Scripps Translational Science Institute
NCT04881019
Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults
Purdue University
NCT03409484
The Breakfast Study
Temple University
NCT00593307
The Impact of Fruit Juice, Fruit Juice With Pomace, or Whole Fruit on Glycemic Response
PepsiCo Global R&D
NCT04369716
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Glycemic Response records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glycemic Response trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glycemic Response page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Glycemic Response trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Scripps Translational Science Institute sponsors the most Glycemic Response trials on record, review their full trial history before evaluating a specific study. See Scripps Translational Science Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glycemic Response condition card totals 5 registered trials; most-linked intervention High GI Low carb; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.